On October 28, the US Department of Health and Human Services told American pharmacies it would stop enforcing the rules that kept them from compounding BPC-157, as long as a list of conditions is met. Within days, social feeds had shortene The post Washington Just Stepped Aside on BPC-157, but the FDA’s Own Count of Human Studies Fits on One Hand: What the New Policy Changes, and Why It Changes Nothing in Costa Rica appeared first on Side Car .